The largest database of trusted experimental protocols

9 protocols using bovine pituitary extract

1

Culturing HSGE Cells from Salivary Gland Tissues

Check if the same lab product or an alternative is used in the 5 most similar protocols
HSGE cells were cultured according to the following experiment process [22 (link)]. The salivary gland tissues were obtained from healthy controls and pSS patients. In short, the tissues were cut with scalpels and fine needles and placed in six-well plates covered with type-I collagen (Iwaki, Tokyo).The medium was then added consisting 100 U/ml penicillin and 100 μg/ml streptomycin (Gibco, New York), 25 μg/ml bovine pituitary extract (Kurabo, Osaka, Japan), 0.4 μg/ml hydrocortisone (Sigma-Aldrich, MO), a limited keratinocyte-SFM medium (Invitrogen Life Technologies, CA), 10% fetal bovine serum(Gibco, New York). The tissue was incubated for several days and photographed on day 3 and day 10. When growth of HSGE cells was observed in vitro, we transferred cells to a 100-mm2 plate after fusion, and the plate was covered with type I collagen (Iwaki). After the HSGE cells reached junction on the 100-mm2 plates, the HSGE cells were cultured on small cell bottle covered with type-I collagen (Iwaki) for the next experiment. Primary cells were observed with a small number of fibroblasts which were removed by means of differential attachment technique.
+ Open protocol
+ Expand
2

Culturing and Stimulation of SGECs

Check if the same lab product or an alternative is used in the 5 most similar protocols
We performed the culturing of SGECs as described [25 (link)]. Briefly, the LSG tissues were cut with fine needles and scalpels and placed in six-well plates coated with type I collagen (Iwaki, Tokyo) with culture medium consisting of defined keratinocyte-SFM culture medium (Invitrogen Life Technologies, Carlsbad, CA, USA), 0.4 μg/mL hydrocortisone (Sigma-Aldrich, St. Louis, MO, USA), 25 μg/mL bovine pituitary extract (Kurabo, Osaka, Japan), 100 U/mL penicillin, and 100 μg/mL streptomycin (Gibco, Grand Island, NY, USA). When an outgrowth of SGECs was observed, the cells were transferred into 100 mm2 plates coated with type I collagen (Iwaki) after the cells reached confluence for the analysis by a Simple Western system.
When the SGECs reached confluence, the cells were treated with 1 mM loxoribine, a TLR7 ligand (InvivoGen, San Diego, CA, USA), for 6 h, and then with 1000 U/mL of interferon (IFN)-β (Betaferon®; Bayer Pharma, Berlin, Germany) for 12 h as described [14 (link)]. For immunofluorescence, SGECs were distributed onto 12 mm2 cover slips coated with a type I collagen, Cellmatrix (Nitta Gelatin, Osaka, Japan) in 24-well plates (Corning, New York, NY, USA) after the SGECs reached confluence on 100 mm2 plates. Subsequently, the SGECs were treated with 1 mM loxoribine for 6 h and 1000 U/mL of IFN-β for 12 h.
+ Open protocol
+ Expand
3

Culturing Human Skin Keratinocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Normal human skin keratinocytes from different donors (Kurabo, Osaka, Japan) were cultured in an MCDB153 medium (Wako Pure Chemical Industries, Osaka, Japan) containing 0.1 mM Ca2+ supplemented with 14.1 mg/L o-phosphorylethanolamine, 6.1 mg/L 2-aminoethanol, 5 mg/L insulin, 180 μg/L hydrocortisone, 100 ng/L epidermal growth factor, and 0.4% (v/v) bovine pituitary extract (Kurabo, Osaka, Japan) at 37 °C in a humidified atmosphere containing 5% CO2.
+ Open protocol
+ Expand
4

Keratinocyte Culture with AKR1C3 SNPs

Check if the same lab product or an alternative is used in the 5 most similar protocols
The primary culture of human epidermal keratinocytes was kindly supported by J-TEC (Gamagori, Japan). Keratinocytes were isolated from 3 patients with each of the 3 types of SNPs in AKR1C3; rs12529 GG and rs12387 AA, rs12529 GC and rs12387 AG, and rs12529 CC and rs12387 GG. Skin tissue obtained from the patients was isolated as individual cells and proliferated according to a protocol using 3T3 cells as feeders36 (link). The completed cell lines were incubated in HuMedia-KG2 medium supplemented with 0.1% insulin, 0.1% human epidermal growth factor, 0.1% hydrocortisone, 0.4% bovine pituitary extract, and 0.1% gentamicin/amphotericin B (Kurabo, Osaka, Japan).
+ Open protocol
+ Expand
5

Newborn vs. Adult Keratinocyte Comparison

Check if the same lab product or an alternative is used in the 5 most similar protocols
Normal human epidermal keratinocytes were purchased from Kurabo (Osaka, Japan). To compare the response of keratinocytes from newborn babies and adults, four different batches of newborn keratinocytes vials from different donors (0 years–1, 2, 3 and 4) and two different batches of adult keratinocytes vials (donors aged 40 years and 57 years) were used (details are summarized in Supplementary Table 1). Cells were cultured in EPILIFETM medium (Thermo Fisher Scientific, Waltham, MA, USA) supplemented with insulin (10 μg mL−1), human recombinant epidermal growth factor (0.1 ng mL−1), hydrocortisone (0.67 μg mL−1), gentamicin (50 μg mL−1), amphotericin B (50 ng mL−1), and bovine pituitary extract (0.4%, v/v), all of which were sourced from Kurabo, at 37 °C in a CO2 incubator. Undifferentiated keratinocytes between passage 2 and passage 6 were used for experiments. EPILIFETM medium contains Mg2+, but the concentration is not disclosed.
For fluorescence imaging, keratinocytes were seeded on glass bottom dishes (IWAKI, Shizuoka, Japan) coated with 5 μg mL−1 collagen (Sigma-Aldrich, Saint Louis, MO, USA) at a concentration of 6–8 × 104 cells mL−1.
+ Open protocol
+ Expand
6

HTLV-1 Infection and Sjögren's Syndrome

Check if the same lab product or an alternative is used in the 5 most similar protocols
A biopsy for the LSGs of the enrolled subjects was performed at the lower lip under local anesthesia. Some LSG samples were sent for the pathological diagnosis of sialadenitis. As reported previously (12) , the remaining samples were used for the culture of SGECs in a defined keratinocyte-serum-free medium (SFM) culture medium (Invitrogen Life Technologies, Carlsbad, CA) supplemented with hydrocortisone (Sigma) and bovine pituitary extract (Kurabo, Osaka, Japan).
For the 1-hr co-cultures with SGECs in the defined keratinocyte-SFM culture medium, we used the HTLV-1-infected T-cell line HCT-5 (16, 17) , which is derived from cerebrospinal fluid cells of a patient with HAM, and the non-HTLV-1 infected T-cell line MOLT-4. HCT-5 cells were subcultured in 20% fetal bovine serum (FBS) in RPMI 1640 medium supplemented with interleukin (IL)-2. MOLT-4 cells were maintained in RPMI 1640 medium with 10% FBS.
Before the co-culturing, HCT-5 and MOLT-4 cells were cultured in 100-mm dishes. Our use of human samples following informed consent from the subjects was conducted with the approval of the Ethics Committee of Nagasaki University Hospital (approval no. 09102822-4).
+ Open protocol
+ Expand
7

Melanocyte Culture and Manipulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Normal human epidermal melanocytes (NHEM) were purchased from Kurabo (Osaka, Japan). NHEM #1, #2, and #3, representing medium, low, and high tyrosinase activities, respectively, were the same as used in our previous study (Kasamatsu et al., 2014; Sasaki et al., 2014) . Unless otherwise stated, NHEM #1 was used in all experiments. Cells were suspended (2 or 5 × 10 5 cells/ml) in MCDB153HAA medium (Research Institute for the Functional Peptides Co., Ltd, Higashine, Yamagata, Japan) supplemented with 1% human melanocyte growth supplement (HMGS; Life Technologies, Carlsbad, CA, USA) and 0.1 mM CaCl 2 (Wako Chemical, Osaka, Japan) and seeded in culture plates of various sizes appropriate for the respective experiments. For the RNA interference experiment, melanocytes were suspended in MCDB153HAA medium supplemented with 0.4% bovine pituitary extract (Kurabo, Osaka, Japan), 1 ng/ml recombinant basic FGF (Sigma-Aldrich, Saint Louis, MO, USA), 5 μg/ml insulin (Sigma-Aldrich), 500 ng/ml hydrocortisone (Sigma-Aldrich), 10 ng/ml PMA (Wako Chemical), and 0.1 mM CaCl 2 .
+ Open protocol
+ Expand
8

Evaluating Skin Cell Responses

Check if the same lab product or an alternative is used in the 5 most similar protocols
The synthetic substrate for elastase, N-succinyl-tri-alanyl-p-nitroaniline (STANA) was purchased from the Peptide Institute Inc (Osaka, Japan). The anti-human NEP (neutral endopeptidase) antibody was purchased from Santa Cruz Biotechnology (CA, USA). Rabbit anti-human MMP-1 (Collagenase Type1) rabbit antibody was purchased from Sigma (MO, USA). Horseradish peroxidase conjugated goat polyclonal anti-mouse IgG was obtained from Transduction Laboratories (NJ, USA), ELISA kits (for IL-1α, IL-1ß, IL-6, IL-8, GM-CSF and endothelin (EDN)-1) were obtained from Endogen (Thermo Fisher Scientific, Yokohama, Japan). Ubiquinol10 was kindly provided by Kaneka (Kaneka QH from Kaneka) via Dr. YY. Human primary keratinocytes (HPKs), human dermal fibroblasts (HDFs), serum-free keratinocyte growth medium (Medium 154S) containing low calcium (0.2 mM), bovine pituitary extract (BPE) and epidermal growth factor (EGF), were obtained from Kurabo (Tokyo, Japan). HaCaT human keratinocytes were kindly supplied by Dr. M. Furue (Kyushu University, School of Medicine, Department of Dermatology). Recombinant human GM-CSF (215-GM-010) was purchased from R&D Systems (MN, USA). Recombinant human IL-1α (200-01A) was obtained from PEPROTECH (London, UK). Other chemicals of reagent grade were purchased from Sigma-Aldrich (MO, USA).
+ Open protocol
+ Expand
9

Serum-free Keratinocyte Growth and Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Serum-free keratinocyte growth medium (Medium 154S) containing low calcium (0.2 mM), bovine pituitary extract (BPE) and epidermal growth factor (EGF) were obtained from Kurabo (Tokyo, Japan). Human primary keratinocytes (HPKs) were purchased from Biopredic Intl (Saint-Gregoire, France). Human HaCaT keratinocytes [22 (link), 23 (link)] were kindly supplied by Dr. M. Furue (Kyushu University, School of Medicine, Department of Dermatology). Rabbit polyclonal anti-TGase 1 (NOV-1184-45: NB100-1844 Lot7E3) was purchased from Novus Biologicals (Littleton, CO, USA). Antibodies to phospho-ERK, ERK, phospho-p38, p38, phospho-JNK, JNK, phospho-AKT and AKT were purchased from Cell Signaling Technology (Danvers, MA, USA). Antibodies to phospho-Ser468/Ser276/Ser536NFκBp65, NFκBp65, phospho-Ser133CREB, CREB, c-Jun, phospho-Ser73c-Jun, c-Fos, ATF-2, phospho-Thr71ATF-2, MSK1 and phospho-Thr581/Ser 376/Ser360MSK1 were also purchased from Cell Signaling Technology. Antibodies to COX-2 and β-actin were obtained from Sigma-Aldrich Corp. (St. Louis, MO, USA). The NFκB activation inhibitor II (JSH-23), the MEK inhibitor (PD98059), the p38 inhibitor (SB203580), the JNK inhibitor (JNK inhibitor II) and H89 were purchased from Calbiochem (San Diego, CA, USA). Other chemicals including AX were obtained from Sigma-Aldrich Corp.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!